• Takeda Pharmaceutical average return on tangible equity for 2023 was -9.72, a 50.93% decline from 2022.
• Takeda Pharmaceutical average return on tangible equity for 2022 was -6.44, a 62.32% increase from 2021.
• Takeda Pharmaceutical average return on tangible equity for 2021 was -17.09, a 346.21% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.